It's been a little over a month since Trinity was presented at #ASHG2024. Save time and labor—Twist Trinity(TM) Sequencing with just 1 hour of hybridization time with our Fast Hyb reagents.
Learn more here: www.twistbioscience.com/resources/pr...
@elembio.bsky.social, @twistbio.bsky.social
🚀 Download our recent poster from #ASHG2024 to learn how our PCR-free Trinity workflow expands what’s possible on a benchtop platform by eliminating or integrating post-hybridization steps onboard an #AVITI system while providing significant performance advantages. bit.ly/3OYpyg0 #Sequencing
🌟 Discover how the #AVITI system enables high-throughput WGS and large insert #sequencing applications, demonstrating flexibility and ability to scale large throughput applications with a benchtop sequencer. Download our recent poster from #ASHG2024 to learn more: bit.ly/4fsn2cN
🎥 Watch our #ASHG2024 workshop on-demand. Hear Catherine Brownstein, MPH, PhD, Harvard University and our own Shawn Levy, PhD share how we’re expanding what’s possible on a single platform with simplified workflows, integrated #multiomic capabilities, and improved scalability. bit.ly/3VlAbgh
Download our recent poster from #ASHG2024 to learn how our Trinity™ workflow expands what’s possible on a benchtop platform by eliminating or integrating post-hybridization steps onboard an #AVITI system while providing significant performance advantages. View the poster: bit.ly/4iggAIq #Genomics
The last two weeks were full of science, meetings with old friends, new ideas, opportunities for collaborations and meeting new people who are doing amazing things.
I feel thankful for being at #ashg2024 and #iscbla2024 presenting our #lupusrgmx work
& This is just the begining 🤭🧬💜
And recently Francesco Cisternino on behalf of our team, Yipei Song, Tim Peters, Clint Miller, and Craig Glastonbury present our ongoing work at the #ASHG2024 👇
x.com/francescocis...
Pretty soon there will be a #preprint. So stay tuned!
@umcutrecht.bsky.social
Spent last week at a great #ASHG2024 meeting in Denver. Was not prepared for winter after the warm fall in the northeast
#ASHG2024 was a blast. I had great discussions with friends and #pacbio collaborators, presented a poster on my new tool SVTopo, welcomed #PacBioVega to the world, and realized than I'm a bigger fan of One Republic than I knew before. Excited for next time!
Ok intersection of #cardiogen #cardiosky and #ashg2024
What were the most interesting cardiac genetics posters & presentations at ASHG this year in Denver?
That's a wrap for this year's #ASHG24 #ASHG2024 meeting! Thank you @GeneticsSociety for another wonderful meeting full of exciting science and the opportunity to catch up with friends and colleagues, and start new collaborations! See you next year in Boston at #ASHG25!!!
Insightful and interesting panel discussion and perspectives on the present and future of human genetics & genomics in the last session of #ASHG24 #ASHG2024
Last speaker of the session is Crystal Lumpkins on The Health Information Environment: Fertile ground for sowing seeds of transformation and moving past the status quo. Importance of community-engaged health communication to reduce disparities in health outcomes #ASHG24 #ASHG2024
Third speaker of the last #ASHG24 #ASHG2024 Symposium from Vertex Pharmaceuticals talking about development of innovative therapies for #CysticFibrosis #SickleCellDisease, pain by targeting Nav1.8 and development of an APOL1 inhibitor for kidney disease.
Heather Hampel: PD-1 inhibitors are now an effective therapy for Lynch Syndrome patients & other cancers with microsatellite instability (MSI). Moreover, MSI produces neopeptides that are being targeted for vaccine development & trials to prevent cancer dev #ASHG24 #ASHG2024
Next, Heather Hampel from City of Hope talking about the story of microsatellite instability discovery and screening for Lynch Syndrome in colorectal & endometrial cancer patients. Importance of cascade testing in Lynch Syndrome families to identify at risk pts #ASHG24 #ASHG2024
David Goldstein: "Everyone agrees that genetic evidence is important for drug dev. But what evidence?" The strongest genetic evidence is for Mendelian disease genes. Few Mendelian genes have been well studied, most haven't. Unrealized potential for therapeutic development #ASHG24 #ASHG2024
Starting now the last scientific session of #ASHG24 #ASHG2024 with the Symposium on The Promise and Payoff of Human Genetics and Genomics: Paths from Bench to Bedside. First talk by David Goldstein talking about the evaluation of rare disease associated genes for drug and therapy development.
You can read the full results of the GUARDIAN pilot study in the very recently published original investigation article in JAMA
#ASHG2024 #ASHG24
jamanetwork.com/journals/jam...
Awesome talk by Wendy Chung on the results of the first 10,000 samples screened through the GUARDIAN genomic newborn screening pilot program in New York! #ASHG24 #ASHG2024 Important insights into the implementation of genomic sequencing for early diagnosis of #RareDiseases
Rare coding variants for actionable conditions have large impact on inpatient healthcare cost highlighting importance & potential benefit of population screening programs #ASHG24 #ASHG2024
☝🏽This is why we need population precision health studies and programs in Latin America!
Sebastian May-Wilson presenting at the 3rd Featured Abstract Plenary session #ASHG24 #ASHG2024 presenting on Quantifying the impact of genetic variation on healthcare cost from 13 biobank studies in 8 countries from the GenCost Consortium.
It's been a great #ASHG2024 so far, with most of the lab present. Great poster presentations from CU HMGGP students Jason Wilson and Lauren Dunn, both of whom had their abstracts selected as 'Reviewer's Choice'. Three more posters from the group this afternoon.
Today's #ASHG24 #ASHG2024 awards ceremony honors Profr. Cynthia Morton with the Leadership Award for her contributions to ASHG as Editor in Chief for #AJHG, Past President and past Committee member.
The Early Career award recognizes Loic Yengo from the University of Queensland. Congratulations! 👏🏽
At #ASHG24 #ASHG2024 and interested in non-coding variants in rare disease?
I am speaking in the session "How Do We Describe and Ascribe Clinical Significance to the Non-coding Genome?" bright and early tomorrow morning 🧬
Thank you for summarizing what's been happening at #ASHG2024 for those who can't attend this year!
With the increase in AI-related research and methodologies in the genomics space, conversations concerning appropriate data use and audit policies should be more common -- especially for trainees
Extremely happy to be at this year's #ASHG Awards ceremony where Profr. Jim Lupski is receiving today the Lifetime Achievement Award along with Profr. Peggy Vance for their contributions to the field of human genetics & genomics.
Standing ovation and recognition for Jim Lupski at #ASHG24 #ASHG2024 👏🏽
